MGMT promoter methylation status in anaplastic meningiomas

被引：0
作者：
Benjamin Brokinkel
Bernhard R. Fischer
Susanne Peetz-Dienhart
Heinrich Ebel
Abolghassem Sepehrnia
Burckhard Rama
Friedrich K. Albert
Walter Stummer
Werner Paulus
Martin Hasselblatt
机构：
[1] University Hospital Münster,Institute of Neuropathology
[2] University Hospital Münster,Department of Neurosurgery
[3] St. Barbara-Klinik Hamm,Department of Neurosurgery
[4] Clemens-Hospital Münster,Department of Neurosurgery
[5] Paracelsus Clinic,Department of Neurosurgery
来源：
Journal of Neuro-Oncology | 2010年 / 100卷
关键词：
Meningioma; Methylation Status; Temozolomide; Astrocytic Tumor; MGMT Promoter Methylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 490
页数：1
相关论文
共 50 条
[31]   Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas [J].
Lu, Jun ;
Li, Xiang ;
Li, Hailiang .
MAGNETIC RESONANCE IMAGING, 2021, 83 :189-195
[32]   Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma [J].
Puehringer, Katharina ;
Czarda, Philipp ;
Iluca, Sebastian ;
Zappe, Katja ;
Weis, Serge ;
Spiegl-Kreinecker, Sabine ;
Cichna-Markl, Margit .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (07)
[33]   Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide [J].
K A van Nifterik ;
J van den Berg ;
W F van der Meide ;
N Ameziane ;
L E Wedekind ;
R D M Steenbergen ;
S Leenstra ;
M V M Lafleur ;
B J Slotman ;
L J A Stalpers ;
P Sminia .
British Journal of Cancer, 2010, 103 :29-35
[34]   Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide [J].
van Nifterik, K. A. ;
van den Berg, J. ;
van der Meide, W. F. ;
Ameziane, N. ;
Wedekind, L. E. ;
Steenbergen, R. D. M. ;
Leenstra, S. ;
Lafleur, M. V. M. ;
Slotman, B. J. ;
Stalpers, L. J. A. ;
Sminia, P. .
BRITISH JOURNAL OF CANCER, 2010, 103 (01) :29-35
[35]   MGMT gene promoter methylation and its correlation with clinicopathological parameters in glioblastomas [J].
Arora, Iteeka ;
Gurav, Mamta ;
Rumde, Rachna ;
Dhanavade, Sandeep ;
Kadam, Vinayak ;
Kurani, Hetakshi ;
Shetty, Omshree ;
Goda, Jayant Sastri ;
Shetty, Prakash ;
Moiyadi, Aliasgar ;
Gupta, Tejpal ;
Jalali, Rakesh ;
Epari, Sridhar .
NEUROLOGY INDIA, 2018, 66 (04) :1106-1114
[36]   Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients [J].
Kavouridis, Vasileios K. ;
Ligon, Keith L. ;
Wen, Patrick Y. ;
Iorgulescu, J. Bryan .
JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) :111-116
[37]   Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation [J].
Emanuela Taioli ;
Camille Ragin ;
Xiao-hong Wang ;
Jiangying Chen ;
Scott M Langevin ;
Ashley R Brown ;
Susanne M Gollin ;
Seymour Garte ;
Robert W Sobol .
BMC Cancer, 9
[38]   MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors [J].
De Maglio, Giovanna ;
Casagrande, Mariaelena ;
Guardascione, Michela ;
Fontanella, Caterina ;
Lutrino, Stefania Eufemia ;
Rihawi, Karim ;
Pisa, Federica Edith ;
Tuniz, Francesco ;
Fasola, Gianpiero ;
Pizzolitto, Stefano ;
Aprile, Giuseppe .
FUTURE ONCOLOGY, 2015, 11 (08) :1201-1209
[39]   MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers [J].
Gutenberg, A. ;
Bock, H. C. ;
Brueck, W. ;
Doerner, L. ;
Mehdorn, H. M. ;
Roggendorf, W. ;
Westphal, M. ;
Felsberg, J. ;
Reifenberger, G. ;
Giese, A. .
BRITISH JOURNAL OF NEUROSURGERY, 2013, 27 (06) :772-778
[40]   Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma [J].
Haque, Waqar ;
Teh, Caitlyn ;
Butler, E. Brian ;
Teh, Bin S. .
JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (01) :137-146
12345